Live Breaking News & Updates on Peter Maccallum Cancer Center|Page 5

Stay updated with breaking news from Peter maccallum cancer center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Olaparib Increases Radioligand Activity in mCRPC, Early Findings Suggest

Enhanced antitumor activity was seen with the addition of the PARP inhibitor olaparib to the radioligand lutetium Lu 177 vipivotide tetraxetan in patients with metastatic castration-resistant prostate cancer. ....

Shahneen Sandhu , Peter Maccallum Cancer Center , Department Of Medical Oncology , Medical Oncology ,

Olaparib Bolsters Lutetium Lu 177 Vipivotide Tetraxetan Activity in mCRPC

Enhanced antitumor activity was shown with the addition of the PARP inhibitor olaparib to the radioligand lutetium Lu 177 vipivotide tetraxetan in patients with metastatic castration-resistant prostate cancer. ....

Shahneen Sandhu , Department Of Medical Oncology , Peter Maccallum Cancer Center , Medical Oncology ,

Barriers to voluntary assisted dying in Victoria cause patient distress, finds study

Barriers to voluntary assisted dying in Victoria cause patient distress, finds study
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Ben White , Ruthie Jeanneret , Benp White , Queensland University Of Technology , Peter Maccallum Cancer Center , Health Law Research , Australian Center , Medical Journal , End Of Life Law , Queensland University ,